Zobrazeno 1 - 10
of 128
pro vyhledávání: '"I Kostoglou-Athanassiou"'
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 2 (2022)
Externí odkaz:
https://doaj.org/article/07060e06f320470a9f200b031ab96419
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
I.G. Karaitianos, G. Lypas, A. Tzortzopoulou, N. Arnogiannaki, P. Tziakou, I.E. Katsoulis, I. Kostoglou-Athanassiou
Publikováno v:
International Journal of Surgery Case Reports
Highlights • EGISTs are very rare mesenchymal tumours which originate from cells outside the gastrointestinal tract and tend to have an aggressive biological behaviour. • There have been only a few previous reports of EGISTs arising in the lesser
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
I. Kostoglou-Athanassiou
Publikováno v:
Hellenic Journal of Surgery. 87:18-23
The treatment of thyroid cancer involves surgery. However, treatment of benign thyroid disease is debatable. Goitre should be treated by surgery if malignancy is suspected and if there are compressive signs and symptoms. Similarly, true recurrence of
Publikováno v:
Endocrine. 37:6-10
Tyrosine kinase receptors have been implicated in thyroid cancer. Therefore, tyrosine kinase inhibitors may be used for the treatment of advanced metastatic thyroid carcinoma. The aim is to present a case of metastatic papillary thyroid carcinoma res
Publikováno v:
Hormone Research in Paediatrics. 60:205-208
Aim: To describe the visualization of recurrent disease by [111In]octreotide and 201Tl scintigraphy in a patient with Hürthle cell thyroid carcinoma, increased thyroglobulin levels, and a negative radio-iodine total-body scan. Methods: Scintigraphy
Autor:
V Alevizou-Terzaki, P Athanassiou, C Proukakis, I. Kostoglou-Athanassiou, E. Georgiou, J Gogas, K. Ntalles, C Markopoulos
Publikováno v:
Europe PubMed Central
In 42 postmenopausal women with breast cancer aged 48-85 (mean age 62.4) years, the blood sex hormone levels were measured before and after 6 months of tamoxifen administration (20 mg daily). Follicle-stimulating hormone and luteinizing hormone level
Autor:
Raphaël Rappaport, A. Caiazza, Ram K. Menon, Yasuhiko Yamamoto, S. Boni, Vittorio Coiro, Edda Weimann, Paolo Chiodera, F. Romao, Kalman Kovacs, D.G. Ikkos, M. Stjemquist, Mark A. Sperling, I. Kostoglou-Athanassiou, G.A. Rodan, Luigi Capretti, Hiroshi Tomoyasu, Yukihiro Nagai, H. Al-Taher, L.J. Hirsch, Yasunori Ozawa, M.G. Magotti, Hiroshi Matsushita, Akira Takeshita, Kenichi Kobayashi, E. Georgiou, K. Ntalles, Stephanie A. Amiel, J.-Y. Reginster, Dietrich A. Stephan, G. Caffarri, Sho-ichi Yamagishi, Hiroshi Kida, M. Degueldre, Yoshimasa Shishiba, A.A.W. Peters, Christoph Brack, Kensou Ohsawa, Gloria S. Romero, Masayuki Taniguchi, J. Gerris, Riccardo Volpi, Shozo Yamada, Yutaka Noto
Publikováno v:
Hormone Research. 45:I-IV
Autor:
J. Gogas, C. Proukakis, I. Kostoglou-Athanassiou, Evangelos Georgiou, C. Markopoulos, K. Ntalles
Publikováno v:
The Breast. 3:14-19
Bone mineral density (BMD) in postmenopausal women with breast cancer and the effect of tamoxifen administration on it has not been adequately studied. For this reason we investigated the long-term effect of tamoxifen on bone mineral density (BMD) of